BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Joint Venture - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://jointventure-msk.com
X-WR-CALDESC:Events for Joint Venture
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260520T110000
DTEND;TZID=Europe/London:20260520T123000
DTSTAMP:20260607T170802
CREATED:20260318T083950Z
LAST-MODIFIED:20260518T182659Z
UID:91-1779274800-1779280200@jointventure-msk.com
SUMMARY:Accelerating MedTech Clinical Trials: New models\, real‑world delivery\, & why the UK can lead
DESCRIPTION:Undertaking clinical trials for MedTech devices in the UK has traditionally been expensive and slow. This webinar (hosted by Orthopaedic Research UK\, in association with clinical trials specialist VerIQ and the National Orthopaedic Alliance) will explore how the delivery of clinical studies in health tech and medical devices can be transformed and the UK become a leader in this area. \n\n\nIt will feature a distinguished group of speakers representing industry\, regulation\, clinical practice\, and clinical research delivery. \n\n\nIf you are involved with an MSK MedTech startup\, or a clinician or researcher thinking about starting commercial studies\, we highly recommend attending this free webinar. \nWebinar agenda: \n\nWelcome & brief introduction to Joint Venture\nMartin Thomas\, Head of Strategy\, ORUK\nIntroduction – Why the UK is well positioned to lead in MedTech clinical trials and the importance of new delivery models\nJoe Dupere\, CEO & co-founder VerIQ\nIndustry perspective on opportunities\, and what developers need from the UK ecosystem\nPaul Gibbons\, Chair of the Orthopaedics Committee\, ABHI and Managing Director\, Corin UK\nUK regulatory environment and the role of regulation in enabling innovation and efficient evidence generation\nDaniel Hill\, Deputy Head of Clinical Investigations\, Innovation and Compliance Group\, MHRA\nClinical site delivery\, NHS participation\, and the importance of coordinated research infrastructure (National Orthopaedic Alliance representative)\nProfessor Peter Kay\, Ex-National Clinical Director Musculoskeletal Services NHS England\nMultinational sponsor perspective on conducting MedTech clinical research in the UK\nJamie McDonald\, Associate Director\, Clinical Science & External Research\, DePuy Synthes Companies of Johnson & Johnson\nQ&A\, Hosted by Martin Thomas\, Head of Strategy\, ORUK & Professor Andy Metcalfe\, VerIQ co-founder and Professor in Trauma & Orthopaedics\, University of Warwick\n\n\n \n \nBook your place
URL:https://jointventure-msk.com/event/medtech-clinical-trials/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://jointventure-msk.com/wp-content/uploads/2026/03/AdobeStock_711851919-scaled.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260630T140000
DTEND;TZID=Europe/London:20260630T153000
DTSTAMP:20260607T170802
CREATED:20260402T085746Z
LAST-MODIFIED:20260526T102942Z
UID:368-1782828000-1782833400@jointventure-msk.com
SUMMARY:Navigating the regulatory landscape - a notified body perspective.
DESCRIPTION:From a Notified Body’s viewpoint\, the fastest route to approval for orthopaedic start‑ups is disciplined preparation\, transparent evidence\, and early alignment with regulatory expectations. This webinar will be delivered by Kiwa (a world leader in testing\, inspection and certification)\, who will explain how certification bodies/notified bodies evaluate orthopaedic devices and how start‑ups can avoid the pitfalls that delay conformity assessment. \nThe webinar will feature a case study from Iestyn Foster\, Co-Founder & CEO of Amotio (an early-stage MSK business\, part-funded by ORUK) on how his company is navigating the regulatory landscape. \nThe agenda will cover: \n\nHow Notified Bodies View Orthopaedic Innovation\nClassification: The First Decision We Check\nWhat We Expect in Early Regulatory Strategy\nWhat a Notified Body Looks for in your QMS\nEvidence Requirements Through Our Lens\nWorking Effectively With Your Notified Body\nPost‑Market Surveillance: A Critical Part of Certification\nCertification as a Strategic Advantage\n\n \nBook your place
URL:https://jointventure-msk.com/event/navigating-the-regulatory-pathway/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://jointventure-msk.com/wp-content/uploads/2026/04/AdobeStock_1735447917-scaled.jpeg
END:VEVENT
END:VCALENDAR